Global X Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund in the Health category. It has $76.76M in assets, an expense ratio of 0.50% and a 1.15% dividend yield. The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Assets under management
$76.76M
Expense ratio
0.50%
Category
Health
Dividend yield
1.15%
NAV
$54.76
Fund family
Global X Funds
Exchange
NASDAQ
Top holdings
The largest positions Global X Genomics & Biotechnology ETF reports, by weight.